Versant Ventures closed its fifth health care-focused venture capital fund with a $305m total that exceeded the San Francisco-based firm's $250m goal.
Versant has now raised $1.9bn in five different funds, which the VC firm invested in biopharmaceutical, medical device and health...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?